American College Of Obstetricians And Gynecologists (ACOG) Annual Meeting

Seattle, Washington 24 April 2020 - 27 April 2020

Obesity tied to multiple negative pregnancy and birth outcomes

12 Jun 2020 by

Women who are obese may have a host of pregnancy-related negative outcomes including pre-eclampsia and large for gestational age (LGA) infants, according to several studies from ACOG 2020.

Obesity tied to multiple negative pregnancy and birth outcomes

12 Jun 2020

Multimodal analgesia cuts opioid use after C-section

09 Jun 2020 by

Implementation of the enhanced recovery after surgery (ERAS) protocols incorporating the use of scheduled multimodal analgesia reduced the need for opioid use in patients undergoing caesarean section (C-section), reveals a retrospective study presented at the ACOG 2020 Meeting.

Multimodal analgesia cuts opioid use after C-section

09 Jun 2020

Menstrual cup use linked to IUD expulsion

09 Jun 2020 by

Among women who use IUDs as contraception, concurrent use of a menstrual cup may increase the risk of IUD expulsion, according to a study presented at ACOG 2020.

Menstrual cup use linked to IUD expulsion

09 Jun 2020

Relugolix combo therapy preserves bone mass in women with heavy period

02 Jun 2020 by

Combining the oral GnRH* receptor antagonist relugolix together with oestradiol and the progestin norethindrone helps protect against bone loss induced by oestrogen deprivation associated with the use of GnRH receptor antagonist monotherapy for treating heavy menstrual bleeding, according to the LIBERTY studies released during the ACOG 2020 Meeting.

Relugolix combo therapy preserves bone mass in women with heavy period

02 Jun 2020

Subgroup findings boost elagolix benefit in uterine fibroid-induced menstrual bleeding

29 May 2020 by

The addition of the oral GnRH* antagonist elagolix to hormonal add-back therapy (E2/NETA**) reduces menstrual blood loss (MBL) in women with heavy menstrual bleeding (HMB) associated with uterine fibroids (UF) and comorbid adenomyosis, with the extension phase showing benefits beyond 6 months, according to data presented at ACOG 2020.

Subgroup findings boost elagolix benefit in uterine fibroid-induced menstrual bleeding

29 May 2020

Vaginal cleansing prior to C-section reduces SSIs

27 May 2020 by

The use of a vaginal cleansing intervention prior to Caesarean delivery reduced the incidence of surgical site infections (SSIs), according to a study presented at ACOG 2020. However, the addition of intravenous (IV) azithromycin prophylaxis had no added impact on SSI rates.

Vaginal cleansing prior to C-section reduces SSIs

27 May 2020

GU symptoms down, sexual satisfaction up with new vaginal contraceptive gel

26 May 2020 by

A novel, investigational vaginal pH regulator (VPR) – a nonhormonal, water-based, petroleum-free contraceptive vaginal gel – improved genitourinary (GU) side effects and sexual satisfaction in women who are at risk of pregnancy but are not aiming to conceive, interim findings from the phase III AMPOWER* trial show.

GU symptoms down, sexual satisfaction up with new vaginal contraceptive gel

26 May 2020

Contraception with LNG-IUD still effective up to 6 years

21 May 2020 by

A levonorgestrel (LNG)-releasing intrauterine device (IUD) maintains high contraceptive efficacy up to 6 years, which is beyond the 5-year period it is currently approved for, according to data from the Mirena Extension Trial (MET) released during the ACOG 2020 Meeting.

Contraception with LNG-IUD still effective up to 6 years

21 May 2020